CRISPR Therapeutics AG

Engineer III, mRNA Process Development-Downstream

CRISPR Therapeutics AG$97K — $108K *
Pharmaceuticals & Biotech
Less than 5 years of experience
Job Overview by Ladders

Qualifications

  • BS in Chemical Engineering or related field with 4-6+ years' experience; MS with 2-5+ years
  • Hands-on experience in downstream process development, especially with nucleic acids
  • Demonstrated scale-up experience in bioprocess engineering
  • Experience in transferring processes to external manufacturers with documentation support
  • Familiar with DoE and statistical analysis tools (e.g., JMP, Design-Expert)
  • Strong communication skills and ability to influence outcomes

Responsibilities

  • Develop and optimize downstream unit operations for mRNA drug substance
  • Select and screen appropriate resins, membranes, and other components
  • Create impurity clearance strategies for various entities
  • Address challenges specific to mRNA processing and purification
  • Define scaling parameters for process fit at CDMOs
  • Manage technology transfer of downstream processes to external partners
  • Collaborate cross-functionally to optimize overall process efficiency

Benefits

  • Full-time on-site position to foster team collaboration
  • Opportunities for professional growth within a pioneering biotech company
  • Access to cutting-edge technology and innovative projects
  • A strong focus on career development and continuous learning
  • Engagement in meaningful work that contributes to mRNA therapeutic advancements
Full Job Description

Job Description:

Position Summary

We are seeking an Engineer III to own downstream process development for mRNA drug substance and to carry those processes into GMP production at external CDMOs. This person will design, develop, and scale the purification process from bench through pilot scale in-house, then facilitate the technical transfer, engineering runs, and GMP campaign support at partner sites. The role is engineering-forward and externally facing.

Responsibilities

Downstream process development

  • Develop and optimize downstream unit operations for mRNA drug substance: DNase treatment and reaction quench, clarification and depth filtration, chromatographic capture and polishing (oligo-dT affinity, ion exchange, reverse phase, hydrophobic interaction, core bead or multimodal), precipitation-based purification, TFF/UFDF, and sterile filtration
  • Screen and select resins, membranes, filters, and single-use components; define binding capacity, loading, buffer, and elution conditions, and generate the data supporting each selection
  • Develop impurity clearance strategies with defined logs or fold reduction for dsRNA, residual template DNA, protein and enzyme, residual nucleotides and small molecules, endotoxin, and truncated or aggregated RNA species
  • Address mRNA-specific downstream challenges including viscosity at high concentration, shear sensitivity, aggregation and HMW species formation, membrane fouling, and product loss across the train

Scale-up and process fit to partner capability

  • Assisting in building scale-up and scale-down models; define scaling parameters, sizing bases, and hold and hydraulic constraints for each unit operation
  • Perform mass balance, yield accounting, and process fit analysis against each CDMO's actual equipment trains, single-use platforms, and facility constraints — and identify early where the process must be adapted or the site is not a fit
  • Contribute to CDMO technical assessment and selection: capability gap analysis, equipment and automation compatibility, analytical readiness, and capacity
  • Design the process to be transferable, favoring platform-standard equipment, commercially available consumables with second sources, and operating ranges that hold at a site you do not control

Technology transfer and external campaign execution

  • Own downstream technology transfer to CDMOs end to end: transfer packages, process descriptions, scale-appropriate parameter tables, risk assessments, gap analyses, and resolution of site-specific questions
  • Review and approve partner-generated documents — batch records, protocols, sampling plans, engineering run plans — and hold the line on parameters that matter while accommodating site practice where it does not
  • Assist with technical readiness for engineering, toxicology, and GMP campaigns; run pre-campaign risk reviews and define the decision criteria and escalation path before the batch starts
  • Serve as person-in-plant at partner sites: real-time data review, in-process decision support, and troubleshooting during execution
  • Drive post-campaign activities: batch data review, yield and impurity reconciliation against the model, deviation investigations, CAPA input, and process improvements for the next campaign
  • Support commercial and quality colleagues on technical content for statements of work, change controls, quality agreements, and tech transfer timelines

Cross-functional collaboration

  • Partner with upstream and IVT process development to co-optimize the process rather than each half in isolation, particularly where reaction conditions drive downstream burden
  • Work with Analytical Development on method suitability, sample plans, method transfer to the CDMO, and interpretation of purity and integrity data
  • Interface with Formulation/LNP on drug substance attributes that affect drug product performance, and with Supply Chain on raw material and consumable lead times, second sourcing, and partner procurement timelines
  • Present development and campaign data at program and platform forums

Minimum Qualifications

  • BS in Chemical Engineering, Biochemical Engineering, Bioengineering, or related field with 4-6+ years of relevant industry experience; MS with 2-5+ years
  • Hands-on downstream process development experience with biologics or nucleic acids, including chromatography and TFF at bench and pilot scale
  • Demonstrated scale-up experience and a working command of mass balance, sizing, and engineering fundamentals applied to bioprocess unit operations
  • Direct experience transferring a process to an external manufacturing partner, including authoring transfer documentation and supporting execution on site
  • Experience with DoE and statistical analysis (JMP, Design-Expert, or equivalent)
  • Strong written and verbal communication, and the ability to influence technical outcomes at a partner site without direct authority

Preferred Qualifications

  • Direct mRNA, plasmid DNA, or oligonucleotide downstream experience, including oligo-dT affinity capture and dsRNA clearance
  • Multiple completed GMP campaigns at CDMOs in a person-in-plant or technical lead capacity
  • Experience with process characterization supporting late-phase development or BLA filing
  • Familiarity with single-use technology selection, extractables and leachables considerations, and partner-site automation or recipe configuration
  • Understanding of LNP formulation and drug product manufacturing as it constrains drug substance specifications

Competencies

  • Collaborative – Openness, One Team
  • Undaunted – Fearless, Can-do attitude
  • Results Orientation – Delivering progress toward our mission. Sense of urgency in solving problems.
  • Entrepreneurial Spirit – Proactive. Ownership mindset.

Due to the nature of their work, our manufacturing and lab-based positions are located fully on-site.  

Base pay range of $97,000 to $108,000+ bonus, equity and benefits

The range provided is CRISPR Therapeutics’ reasonable estimate of the base compensation for this role. The actual amount will be based on job-related and non-discriminatory factors such as experience, training, skills, and abilities.

About CRISPR Therapeutics AG

CRISPR Therapeutics AG, a gene editing company, focuses on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. The company develops its products through in-house research programs and partnerships with biopharmaceutical companies and academic researchers. Its lead product candidate is CTX001, an ex vivo CRISPR gene-edited therapy for treating patients suffering from transfusion-dependent beta thalassemia or severe sickle cell disease in which a patient's hematopoietic stem cells are engineered to produce high levels of fetal hemoglobin in red blood cells. The company was formerly known as Inception Genomics AG and changed its name to CRISPR Therapeutics AG in April 2014. CRISPR Therapeutics AG was founded in 2013 and is headquartered in Zug, Switzerland.
Learn more about CRISPR Therapeutics AG
Size
473 employees
Market Cap
$3.3 billion
Industry
Net Income
-$348.8 million
Founded
2013
5 Year Trend
+181.6%
Revenue
$720,000
NASDAQ

Similar Jobs

More Jobs at CRISPR Therapeutics AG

More Pharmaceuticals & Biotech Jobs

Find similar Engineer III, mRNA Process Development-Downstream jobs: